Nerve Biologic Products Market, by Product Type, Application and Region Outlook, Opportunity Analysis, 2018 – 2026
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Nerve Biologic Products Market
Nerve biologic products include artificial nerve conduit, nerve graft, nerve wraps, or nerve capping devices used for guiding axonal regrowth to facilitate nerve regeneration. These devices are majorly used in clinical treatments of nerve injuries. Nerve biologic products are commonly used for complex suturing, for instance, suturing of the two ends of a separated nerve. The scaffold material used for generating nerve biologic products is either from synthetic or biological origin. The nerve biologic products are manufactured from various biocompatible products, such as polysialic acid (PSA), collagen type I/III, spider silk fiber, silkworm silk fibroin, chitosan, aragonite, and alginate.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2265
Global Nerve Biologic Products Market – Drivers
Advancements in R&D for developing innovative technologies for nerve biologic products are expected to drive the growth of the global nerve biologic products market. For instance, in February 2015, researchers from the University of Sheffield developed a device, 3D-printed nerve guidance conduit (NGC). NGC is a network of miniature tubes, which guide injured nerve ends towards each other, thereby enabling them to repair naturally. The device uses computer-aided design (CAD), which can be modified for any type of nerve damage or even adapted for joint specific nerves of patient.
Furthermore, in June 2016, Polyganics, a medical device manufacturing company, received the CE mark for Neurocap, its nerve capping device. Neurocap is an absorbable implant for treatment and reduction of symptomatic neuroma in peripheral nerves. The device was cleared for sales in the U.S. in January 2016.
According to the latest report, the U.S. Food and Drug Administration’s clearances for nerve biologic products would supplement the growth of the global market. For instance, in June 2014, Collagen Matrix Inc. received USFDA clearance for its Flexible Collagen Nerve Conduit. Flexible Collagen Nerve Conduit is a resorbable and flexible type I collagen tubular matrix that offers encasement for peripheral nerve injuries as well as shielding of the neural environment.
In May 2015, AxoGen, Inc. received the U.S. FDA clearance to proceed for its Investigational New Drug (IND) application for the Avance Nerve Graft. The product is commercially available while it is transitioned to a biologic product due to USFDA’s enforcement discretion grant. It has porcine submucosa extracellular matrix used to wrap and protect injured peripheral nerves and strengthen the nerve reconstruction while preventing soft tissue attachments.
Product recall by the U.S. FDA due to contamination and sterility issues is expected to limit the growth of the global nerve biologic products market. For instance, in June 2015, USFDA recalled NeuraWrap Nerve Protector and Dural Graft Matrix, manufactured by Integra LifeSciences, due to process deviation in manufacturing, and higher levels of pyrogens than acceptable by the specifications for the products. NeuraWrap Nerve Protector was specified for management of peripheral nerve injuries while Dural Graft Matrix was an absorbable implant for repair of dural defects.
To know the latest trends and insights related to Nerve Biologic Products Market: https://www.coherentmarketinsights.com/ongoing-insight/nerve-biologic-products-market-2265
Global Nerve Biologic Products Market – Regional Outlook
Among regions, North America is expected to hold the leading position in the global nerve biologic products market over the forecast period, owing to the rising incidence of peripheral nerve injuries in the U.S. Based on the proceedings of the National Academy of Sciences of the U.S. study carried out in June 2017, over 250,000 people in the U.S. suffer from peripheral nerve injuries each year.
Asia Pacific and Europe are foreseen to observe tremendous growth in the nerve biologic products market. This is attributed to rising awareness of central nervous system disorders and therapeutic treatments through organized conferences. For instance, the 6th International Conference on Central Nervous System (CNS) Disorder and Therapeutics was held in Paris (Europe) in November 2018, while, the 7th International Conference on Central Nervous System (CNS) Disorder and Therapeutics was conducted in Japan (Asia Pacific) in June 2019. These conferences mainly discusses on topics such as diseases and disorders of the CNS, neuroimmunological disorders, neurometabolic disorders, brain tumors, and neurosurgery.
The key players operating in the global nerve biologic products market include Stryker, AxoGen, Inc., Integra LifeSciences, Collagen Matrix, Inc., Polyganics, Checkpoint Surgical Inc., and Texas Pharmaceuticals Pvt. Ltd.
By Product Type,
- Nerve Wraps
- Nerve Grafts
- Nerve Conduit
- Nerve Capping
- Nerve Grafting
- Direct Nerve Repair/ Neurorrhaphy
- Dural Defects
- Peripheral Nerve Injuries
- North America
- Asia Pacific
- Latin America
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire